Is The Bad News Priced Into Nike Stock Now?
Despite its dominance in the athletic shoe and apparel industry,…
Buy
70
OPCH Quote, Financials, Valuation and Earnings
Last price:
$34.92
Seasonality move
:
18.87%
Day range:
$34.52 - $35.03
52-week range:
$21.39 - $35.53
Dividend yield:
0%
P/E ratio:
28.52x
P/S ratio:
1.20x
P/B ratio:
4.10x
Volume:
1.3M
Avg. volume:
1.9M
1-year change:
8.75%
Market cap:
$5.8B
Revenue:
$5B
EPS (TTM):
$1.22
Analysts' Opinion
-
Consensus RatingOption Care Health has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.78, Option Care Health has an estimated upside of 8.59% from its current price of $34.79.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $33.00 representing 100% downside risk from its current price of $34.79.
Fair Value
-
According to the consensus of 7 analysts, Option Care Health has 8.59% upside to fair value with a price target of $37.78 per share.
OPCH vs. S&P 500
-
Over the past 5 trading days, Option Care Health has underperformed the S&P 500 by -2.26% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Option Care Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Option Care Health has grown year-over-year revenues for 20 quarters straight. In the most recent quarter Option Care Health reported revenues of $1.3B.
Earnings Growth
-
Option Care Health has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Option Care Health reported earnings per share of $0.35.
Enterprise value:
6.4B
EV / Invested capital:
--
Price / LTM sales:
1.20x
EV / EBIT:
19.39x
EV / Revenue:
1.29x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
22.41x
Price / Operating cash flow:
20.90x
Enterprise value / EBITDA:
16.28x
Gross Profit (TTM):
$1B
Return On Assets:
6.36%
Net Income Margin (TTM):
4.24%
Return On Equity:
14.93%
Return On Invested Capital:
8.44%
Operating Margin:
6.46%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.9B | $4.3B | $5B | $1.1B | $1.3B | |
| Gross Profit | $866.9M | $981.2M | $1B | $247.1M | $268.4M | |
| Operating Income | $240.2M | $314.6M | $321.8M | $84.6M | $87M | |
| EBITDA | $325M | $472.2M | $396.1M | $107.1M | $109.4M | |
| Diluted EPS | $0.83 | $1.47 | $1.22 | $0.32 | $0.35 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $657M | $710.3M | $994.3M | $1.1B | $1.3B | |
| Total Assets | $2.6B | $2.8B | $3.1B | $3.2B | $3.4B | |
| Current Liabilities | $434M | $459.7M | $565.4M | $618.3M | $780.1M | |
| Total Liabilities | $1.6B | $1.6B | $1.7B | $1.8B | $2B | |
| Total Equity | $1B | $1.2B | $1.4B | $1.4B | $1.4B | |
| Total Debt | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $267.5M | $371.3M | $323.4M | $51M | $36.1M | |
| Cash From Investing | -$108.1M | -$56.5M | -$36.5M | -$15.8M | -$11.2M | |
| Cash From Financing | $15.3M | -$265.1M | -$218.2M | -$77.8M | -$95.4M | |
| Free Cash Flow | $232.2M | $329.4M | $287.8M | $31.1M | $25.8M | |
OPCH
Sector
Market Cap
$5.8B
$35.9M
Price % of 52-Week High
97.92%
43.21%
Dividend Yield
0%
0%
Shareholder Yield
6.3%
-0.91%
1-Year Price Total Return
8.75%
-43.29%
Beta (5-Year)
1.074
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$34.94
200-day SMA
Buy
Level
$29.02
Bollinger Bands (100)
Buy
Level
23.21 - 32.93
Chaikin Money Flow
Buy
Level
33.8M
20-day SMA
Buy
Level
$34.26
Relative Strength Index (RSI14)
Buy
Level
61.58
ADX Line
Buy
Level
35.62
Williams %R
Neutral
Level
-22.561
50-day SMA
Buy
Level
$32.62
MACD (12, 26)
Buy
Level
0.77
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
155.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3928)
Buy
CA Score
(Annual)
Level (0.2372)
Buy
Beneish M-Score
(Annual)
Level (-2.5121)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.1907)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Stock Forecast FAQ
In the current month, OPCH has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The OPCH average analyst price target in the past 3 months is $37.78.
-
Where Will Option Care Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Option Care Health share price will rise to $37.78 per share over the next 12 months.
-
What Do Analysts Say About Option Care Health?
Analysts are divided on their view about Option Care Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Option Care Health is a Sell and believe this share price will drop from its current level to $33.00.
-
What Is Option Care Health's Price Target?
The price target for Option Care Health over the next 1-year time period is forecast to be $37.78 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is OPCH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Option Care Health is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OPCH?
You can purchase shares of Option Care Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Option Care Health shares.
-
What Is The Option Care Health Share Price Today?
Option Care Health was last trading at $34.92 per share. This represents the most recent stock quote for Option Care Health. Yesterday, Option Care Health closed at $34.79 per share.
-
How To Buy Option Care Health Stock Online?
In order to purchase Option Care Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 10.04% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 7.68% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 7.29% over the past day.
